Exchange: NASDAQ
-2.33% $153.66
America/New_York / 25 apr 2024 @ 11:37
FUNDAMENTALS | |
---|---|
MarketCap: | 441.51 mill |
EPS: | 9.88 |
P/E: | 15.55 |
Earnings Date: | N/A |
SharesOutstanding: | 2.87 mill |
Avg Daily Volume: | 0.0072 mill |
PE RATIO: COMPANY / SECTOR |
---|
1.06x |
Company: PE 15.55 | sector: PE 14.70 |
PE RATIO: COMPANY / INDUSTRY |
---|
0.90x |
Company: PE 15.55 | industry: PE 17.27 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 151.81 - 155.51 ( +/- 1.20%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $153.66 (-2.33% ) |
Volume | 0.0517 mill |
Avg. Vol. | 0.0072 mill |
% of Avg. Vol | 722.58 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.